First RSV antibody treatment to protect all infants approved in the U.S.

The shot provides vaccine-like protection to healthy babies during a single winter respiratory virus season. But Sean O’Leary, a pediatric infectious-disease specialist at Children’s Hospital Colorado, said he expected logistical, educational and possible financial hurdles that could delay the drug’s rollout before this year’s winter respiratory virus season.